price
ER
NASDAQ · ERAS
Erasca, Inc.
Healthcare · Biotechnology
$14.35
Down-$0.63 (-4.21%)
Updated Nov 2, 2026, 8:22 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 958.95M
- P/E ratio
- -7.47
- Dividend yield
- 0.00%
- 52-week range
- $2.11 – $24.28
- Volume
- 3.75M
- Avg. volume
- 1.84M
Price performance · ERAS
ERAS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ERAS closed at $14.35 after 20 trading sessions, down 2.51% for the selected period.
- Last close
- $14.35
- Period change
- -2.51%
- Period low
- $13.39
- Period high
- $16.03
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $14.66 | $15.01 | $14.035 | $14.35 | 3.75M |
| Oct 29, 2026 | $15.11 | $15.45 | $14.66 | $14.98 | 2.28M |
| Oct 28, 2026 | $14.90 | $15.32 | $14.45 | $15.12 | 3.41M |
| Oct 27, 2026 | $14.95 | $15.26 | $14.72 | $15.22 | 5.83M |
| Oct 26, 2026 | $14.58 | $15.47 | $14.545 | $14.99 | 6.47M |
| Oct 23, 2026 | $13.99 | $14.445 | $13.44 | $14.39 | 3.5M |
| Oct 22, 2026 | $14.22 | $14.645 | $13.815 | $14.04 | 2.3M |
| Oct 21, 2026 | $14.82 | $15.05 | $14.38 | $14.49 | 3.85M |
| Oct 20, 2026 | $13.40 | $14.97 | $13.10 | $14.62 | 4.22M |
| Oct 19, 2026 | $13.73 | $13.98 | $13.34 | $13.62 | 4.26M |
| Oct 16, 2026 | $14.87 | $14.87 | $13.265 | $13.39 | 7.09M |
| Oct 15, 2026 | $14.71 | $15.26 | $14.36 | $14.87 | 8.48M |
| Oct 14, 2026 | $14.41 | $15.08 | $14.29 | $14.70 | 4.75M |
| Oct 13, 2026 | $15.25 | $15.5799 | $14.50 | $14.78 | 5.31M |
| Oct 12, 2026 | $15.885 | $16.01 | $15.32 | $15.46 | 4.28M |
| Oct 9, 2026 | $15.42 | $16.20 | $15.215 | $16.03 | 7.77M |
| Oct 8, 2026 | $13.96 | $15.62 | $13.7802 | $15.46 | 9.61M |
| Oct 7, 2026 | $14.09 | $14.57 | $13.93 | $14.12 | 3.85M |
| Oct 6, 2026 | $14.74 | $14.93 | $14.02 | $14.30 | 8.04M |
| Oct 5, 2026 | $14.74 | $15.03 | $13.8034 | $14.72 | 5.49M |
Latest ERAS news
The latest Smart Investors Daily articles mentioning ERAS.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

